PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'UNION therapeutics Research Services, Hellerup, Denmark.\', \'Novo Nordisk Center for Biosustainability, Technical University Denmark, Lyngby, Denmark.\', \'Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207-IHU Méditerranée, Infection), Marseille, France.\', \'Institute Pasteur, Paris, France.\', \'UNION Therapeutics, Hellerup, Denmark.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1371/journal.pone.0260958
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 34855904
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
?:title
  • Niclosamide shows strong antiviral activity in a human airway model of SARS-CoV-2 infection and a conserved potency against the Alpha (B.1.1.7), Beta (B.1.351) and Delta variant (B.1.617.2).
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all